Bay Capital Advisors LLC Takes Position in Humana Inc. (NYSE:HUM)

Bay Capital Advisors LLC bought a new position in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, Holdings Channel.com reports. The fund bought 800 shares of the insurance provider’s stock, valued at approximately $203,000.

Several other hedge funds have also recently added to or reduced their stakes in HUM. Transcend Capital Advisors LLC increased its position in shares of Humana by 399.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock valued at $924,000 after purchasing an additional 2,914 shares during the last quarter. FNY Investment Advisers LLC increased its holdings in Humana by 6,647.5% in the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after buying an additional 26,856 shares during the last quarter. Retirement Systems of Alabama increased its holdings in Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after buying an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Humana by 7.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock worth $244,811,000 after buying an additional 65,735 shares during the last quarter. Finally, PDT Partners LLC lifted its holdings in Humana by 190.0% during the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock worth $1,286,000 after buying an additional 2,660 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Up 2.1 %

Shares of NYSE:HUM opened at $271.65 on Tuesday. The company has a market cap of $32.79 billion, a price-to-earnings ratio of 27.30, a PEG ratio of 2.05 and a beta of 0.57. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The firm’s 50-day simple moving average is $271.01 and its 200-day simple moving average is $275.60. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.30%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on HUM shares. Truist Financial raised their target price on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Cantor Fitzgerald restated a “neutral” rating and issued a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Piper Sandler lifted their price target on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Morgan Stanley decreased their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Eighteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $285.68.

Insider Activity

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.37% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.